Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Raymond March
50 POSTS
0 COMMENTS
Raymond J. March
is a Research Fellow at the Independent Institute and Assistant Professor of Economics at North Dakota State University.
All Blog Posts
|
Full bio and publications
FDA Approves $2 Million Drug. Blame the Price on Excessive Regulation.
Raymond March
-
May 30, 2019
0
FDA To Stop Regulating the Amount of Cherries in Frozen Cherry...
Raymond March
-
May 15, 2019
0
Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments...
Raymond March
-
May 7, 2019
0
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Raymond March
-
March 28, 2019
0
Generic Insulin Now Available After Nearly One Hundred Years of Regulatory...
Raymond March
-
March 25, 2019
0
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond March
-
March 14, 2019
0
FDA Panel Backs Ketamine-Based Treatment for Depression
Raymond March
-
March 1, 2019
0
Let Competition, Not Politicians, Bring Insulin Prices Down
Raymond March
-
February 20, 2019
0
Right-to-try Laws Help Patient with Terminal Brain Cancer
Raymond March
-
February 1, 2019
0
FDA Approves Record Number of Generic Drugs in 2018
Raymond March
-
January 9, 2019
0
1
2
3
...
5
Page 2 of 5
Edit with Live CSS
